Ursodiol
- TRADE NAMES: Actigall (Watson); Adursall; Arsacol; Biliepar; Cholacid; Cholit-Ursan; Cholofalk; Coledos; Delursan; Desocol; Desoxil; Destolit (Norgine); Deurcil; Dexo; Estazor; Fraurs; Galmax; Lentorsil; Litanin; Litocure; Litoff; Litursol; Lyeton; Peptaron; Solutrat; UDC; UDC Hexal; Urdox (Wockhardt); Urso 250 (Aptalis); Urso Forte (Aptalis); Urso Heumann; Urso Vinas; Ursochol; Ursofal; Ursofalk; Ursoflor; Ursogal (Galen); Ursolac; Ursolism; Ursolvan; Urson; Ursoproge; Ursosan; Ursotan; USCA
- INDICATIONS: The dissolution of radiolucent (i.e. non-radio opaque) cholesterol gallstones in patients with a functioning gallbladder; primary biliary cirrhosis; biliary calculus; cholelithiasis
- SYNONYM: ursodeoxycholic acid; UDCA
- CLASS: Cholesterol antagonist, Urolithic
- HALF-LIFE: 100 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aluminum based antacids, Aluminum hydroxide, Charcoal, Cholestyramine, Clofibrate, Colestimide, Colestipol, Cyclosporine, Dapsone, Estradiol, Estrogens, Nitrendipine, Oral Contraceptives, P4503A substrates
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
HAIR.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric